CLOV vs CSTL · rev $1.37B vs rev $332.1M
Clover Health Investments Corp (CLOV) versus Castle Biosciences Inc (CSTL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CSTL revenue for 2024-12-31 was $332.1M. Net income was $18.2M. Revenue was up 51.1% from 2023-12-31 to 2024-12-31. CSTL currently screens at market cap $570.2M.
CLOV currently screens at market cap $1.55B. CSTL currently screens at market cap $570.2M.
Not investment advice. Open the CLOV and CSTL stock pages for the full models.
Not investment advice.